1) Cys-RGD peptide
Cys-RGD肽
1.
The Cys-RGD peptide is labelled with 99Tcm-nitrido core combined with PNP6 ligand (PNP6=bis(diethoxypropylphosphino ethyl) ethoxy ethylamine) to investigate the possibility of radiolabelled RGD peptides for tumor αvβ3 integrin receptor scintigraphy.
为探讨99Tcm标记的小分子环形Cys-RGD肽用于αvβ3受体阳性肿瘤显像的可行性,以99Tcm(N)核联合协同配体二膦基胺类化合物二[二(乙氧基丙基膦)-乙基]-乙氧基乙基胺(PNP6)对环形Cys-RGD肽(c(Arg-Gly-Asp-D-Tyr-Lys)-Cys)进行了标记,并考察了标记物的体外稳定性及正常小鼠和荷FWK-1胰腺癌裸鼠模型的体内生物分布和平面显像。
2) RGD peptide
RGD肽
1.
Influence of RGD peptide on the proliferation and adhesion of human lens epithelial cells in vitro;
RGD肽对体外培养的人晶状体上皮细胞粘附与增殖的影响
2.
By studying the distribution and imaging of ~(131)Ⅰlabelled cyclic RGD(cRGD)peptide in mice bearing melanoma,we will discuss the possibility of ~(131)Ⅰ-cRGD peptide as tumor receptor radiotracer.
目的研究~(131)I标记含精氨酸-甘氨酸-天冬氨酸的小分子环形肽(cRGD肽)在荷瘤小鼠体内的分布与显像,探讨~(131)I-cRGD肽作为肿瘤诊治药物的可能性。
3.
Objective To prepare the conjugate of yunnanmycin(YNM) and RGD(Arg-Gly-Asp) peptide for enhancing the cytotoxicity of RGD peptide.
目的制备云南霉素(yunnanmycin,YNM)与抗黏附肽RGD(Arg-Gly-Asp)的偶联物,增强RGD肽的细胞毒作用。
4) RGD identical-fork-peptide
RGD均叉肽
1.
Synthesis of RGD identical-fork-peptide derivative with inhibitive effect on adhesiveness of advanced metastatic tumor cells;
RGD均叉肽合成及其对高转移肿瘤细胞的黏附抑制作用
5) RGD-containing peptide
含RGD肽
1.
Isolation and identification of rabbit autogenous bone marrow stromal cells and the expression of exogenous transforming growth factorβ1 gene transiently transfected with RGD-containing peptide gene delivery system;
固相合成法合成含RGD肽K16GRGDSPC(K16-RGD)。
6) RGD
RGD多肽
1.
Modulation of adhesion,proliferation and differentiation of mesenchymal stem cells cultured on PLGA modified with RGD peptide;
RGD多肽修饰的改性PLGA仿生支架材料对骨髓间充质干细胞粘附、增殖及分化影响的研究
2.
Synthesis of RGD-aPEG-Lactoside, A Potential Anti-metastasis Glycoconjugate;
RGD多肽-氨基聚乙二醇-乳糖苷糖缀合物的合成(英文)
3.
Specific Binding of Integrin α_(Ⅱb) β_3 to RGD Peptide: a Surface Plasmon Resonance Study;
表面等离激元共振生物传感器研究整合素蛋白α_(Ⅱb) β_3与RGD多肽的特异结合
补充资料：N-CBZ-S-benzyl-L-cys
分子式：C18H19NO4S
分子量：345.42
CAS号：暂无
性质：该品为白色固体粉末，熔点94-96℃，不溶于水，溶与酸，易溶于丙酮、乙醇等有机溶剂。
制备方法：暂无
用途：该产品是治疗艾滋病新药“佛雷赛普特(Viracept)”的关键中间体。
分子量：345.42
CAS号：暂无
性质：该品为白色固体粉末，熔点94-96℃，不溶于水，溶与酸，易溶于丙酮、乙醇等有机溶剂。
制备方法：暂无
用途：该产品是治疗艾滋病新药“佛雷赛普特(Viracept)”的关键中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条